PHATHOM PHARMACEUTICALS INC's ticker is PHAT and the CUSIP is 71722W107. A total of 85 filers reported holding PHATHOM PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $9,218,000 | -66.2% | 1,092,212 | -45.4% | 0.01% | -53.8% |
| Q1 2022 | $27,238,000 | -24.8% | 2,001,442 | +8.7% | 0.01% | -13.3% |
| Q4 2021 | $36,218,000 | -42.1% | 1,841,357 | -5.5% | 0.02% | -44.4% |
| Q3 2021 | $62,531,000 | -5.4% | 1,948,002 | -0.2% | 0.03% | -3.6% |
| Q2 2021 | $66,067,000 | -10.0% | 1,951,634 | -0.1% | 0.03% | -17.6% |
| Q1 2021 | $73,414,000 | +14.0% | 1,954,448 | +0.8% | 0.03% | +13.3% |
| Q4 2020 | $64,396,000 | +11.9% | 1,938,436 | +23.6% | 0.03% | 0.0% |
| Q3 2020 | $57,538,000 | +10.8% | 1,568,796 | -0.6% | 0.03% | +3.4% |
| Q2 2020 | $51,951,000 | +23.2% | 1,578,679 | -5.3% | 0.03% | 0.0% |
| Q1 2020 | $42,175,000 | -3.2% | 1,667,577 | +13.6% | 0.03% | +31.8% |
| Q4 2019 | $43,589,000 | – | 1,467,462 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Medicxi Ventures Management (Jersey) Ltd | 2,067,861 | $77,669,000 | 45.24% |
| FRAZIER MANAGEMENT LLC | 5,827,415 | $218,878,000 | 17.56% |
| Abingworth LLP | 1,203,135 | $45,057,000 | 15.56% |
| Greenspring Associates, LLC | 360,939 | $13,557,000 | 10.78% |
| Penn Mutual Asset Management, LLC | 86,940 | $3,265,000 | 3.69% |
| RA Capital Management | 3,115,008 | $117,000,000 | 1.76% |
| Rhenman & Partners Asset Management AB | 175,000 | $6,573,000 | 0.46% |
| Summit Rock Advisors, LP | 34,100 | $1,281,000 | 0.44% |
| Eventide Asset Management | 600,000 | $22,536,000 | 0.33% |
| Parkman Healthcare Partners LLC | 30,207 | $1,135,000 | 0.26% |